FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2023770 · Received March 18, 2011

Report

Report Number
2134265-2011-01043
Event Type
Injury
Date Received
March 18, 2011
Date of Event
April 21, 2010
Report Date
February 24, 2011
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

SAME CASE AS MFR REPORT #: 2134265-2011-04410. (B)(6). IT WAS REPORTED THAT FOLLOWING A STENTING TREATMENT PROCEDURE, THE PATIENT PRESENTED WITH RESTENOSIS. THE INDEX PROCEDURE TREATED THE 99% STENOSED, 3.0X40MM TARGET LESION LOCATED IN THE PROXIMAL LEFT CIRCUMFLEX (LCX) ARTERY. TREATMENT PLACED TWO OVERLAPPING TAXUS LIBERTE STENTS (2.5X32MM, 3.0X12MM) RESULTING IN 0% RESIDUAL STENOSIS. THE PATIENT WAS DISCHARGED THE NEXT DAY ON ASPIRIN AND CLOPIDOGREL. IN (B)(6) 2010, WITH NO ISCHEMIC SYMPTOMS THE PATIENT UNDERWENT ANGIOGRAPHY REVEALING A 75% STENOSED, 3.0X18MM LESION LOCATED IN THE PROXIMAL LEFT CIRCUMFLEX (LCX) ARTERY. TREATMENT UTILIZED BALLOON ANGIOPLASTY AND PLACED A NON BSC STENT RESULTING IN 0% RESIDUAL STENOSIS. A LESION LOCATED IN THE DISTAL LEFT ANTERIOR DESCENDING ARTERY WAS ALSO TREATED WITH BALLOON ANGIOPLASTY AND THE PLACEMENT OF A NON-BSC STENT. THE OUTCOME WAS LISTED AS "RESOLVED" AND THE PATIENT WAS DISCHARGED THE NEXT DAY. PER THE PHYSICIAN, THE EVENT WAS LISTED AS "POSSIBLY RELATED" TO THE STUDY STENT. NO ANGINA WAS CONFIRMED AT THE 9 MONTH AND 1 YEAR STUDY FOLLOW UP VISITS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - GALWAY H7493893612300

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention 2.5X32MM TAXUS LIBERTE